Lemonade's IFP Miss: Growth Pause or Buying Opportunity?

Lemonade (LMND) reported its second-quarter earnings on July 29, and the stock took a hit. Revenue surged 79% year over year to $294 million, beating analyst expectations by $3 million. The company also narrowed its net loss to $43.4 million, or $0.56 per share, which matched consensus estimates. These headline numbers looked solid, but the market focused on the full-year in-force premium (IFP) guidance, which came in slightly below Wall Street's target.

For 2026, Lemonade expects IFP to grow 32%-33%, GEP to grow 31%, and revenue to increase 65%. This guidance was actually higher than what the company provided in the first quarter, which called for 32% IFP growth, 30%-31% GEP growth, and 62%-63% revenue growth. The only issue was that the high end of the IFP guidance ($1.639 billion) fell short of analysts' expectations of $1.642 billion.

Lemonade also reiterated its goal of achieving positive adjusted EBITDA by the fourth quarter of 2026. The company's customer base grew 23% year over year to 3.31 million, and its gross loss ratio improved significantly to 64% from 90% in 2021. These metrics indicate that Lemonade's business is fundamentally strong, even if the guidance wasn't as aggressive as some hoped.

The stock's decline seems to be a reaction to the slight guidance miss, but the underlying fundamentals tell a different story. Lemonade is growing rapidly, improving its margins, and moving toward profitability. The pullback might be more about valuation normalization than a slowdown in growth.

Investors should consider the broader context: Lemonade's digital-first approach to insurance is resonating with younger customers, and its expansion into new products like pet, life, and auto insurance is driving growth. The company's long-term prospects remain promising, and the recent dip could be a buying opportunity for those who believe in the story.

Lemonade's stock price is heavily influenced by its growth metrics, particularly IFP and customer growth. The slight miss in IFP guidance raised concerns that the company's growth might be slowing. However, the actual numbers show that Lemonade is still growing at a rapid pace, with IFP growth of 31% in 2025 and expected 32-33% growth in 2026. This is far from a growth stall.

The market's reaction highlights the high expectations placed on high-growth stocks. Even a minor shortfall can trigger a sell-off, but for long-term investors, this could be an opportunity to buy a quality company at a more reasonable price. Lemonade's enterprise value is $4.03 billion, which is only three times this year's sales. That's a bargain for a company growing revenue at 65%.

Lemonade's competitive position is also strengthening. Its gross loss ratio has improved from 90% in 2021 to 64% in 2025, indicating better underwriting and claims management. The company's adjusted gross margin has risen to 41%, showing that it's becoming more efficient. These improvements are crucial for achieving profitability.

The company's expansion into new insurance lines, particularly auto insurance through the Metromile acquisition, is diversifying its revenue streams. This reduces reliance on any single product and provides more growth avenues. As Lemonade scales, its fixed costs are spread over a larger base, which should drive further margin expansion.

For investors, the key takeaway is that Lemonade's growth story is intact. The guidance miss was minor and largely due to conservative estimates. The company is on track to achieve positive adjusted EBITDA by the end of 2026, which would be a major milestone. The recent pullback in the stock price offers a compelling entry point for those with a long-term horizon.